This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fraser, S. L. Articles by Jorgensen, J. H. Search for Related Content PubMed PubMed Citation Articles by Fraser, S. L. Articles by Jorgensen, J. H.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., Dec 1997, 2738-2741, Vol 41, No. 12
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing

SL Fraser and JH Jorgensen
Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas 78234-6200, USA.

Several Flavobacterium species, comprising a heterogeneous group of gram-negative bacilli that are capable of causing opportunistic infections in humans, have recently been reclassified as Chryseobacterium or Myroides species. Intrinsically resistant to a number of antibiotics, these organisms have been reported to be susceptible to vancomycin and certain other drugs that are normally active against gram-positive bacteria. By using the National Committee for Clinical Laboratory Standards (NCCLS) broth microdilution procedure, 58 clinical isolates of former flavobacteria (36 Chryseobacterium meningosepticum isolates, 11 C. indologenes isolates, 3 C. gleum isolates, 4 unspeciated former members of Flavobacterium group IIb, and 4 Myroides odoratum isolates) were tested with 23 antibiotics, including conventional and investigational agents. In addition, the broth microdilution results were compared to those generated by agar dilution, E-test, and disk diffusion for vancomycin and piperacillin-tazobactam. Compared to the NCCLS microdilution results, there were 7.1 and 17.9% very major errors with piperacillin- tazobactam by agar dilution and E-test, respectively. In addition, there were from 12.1 to 48.3% minor errors with both procedures with vancomycin and piperacillin-tazobactam. The very major and minor error rates were unacceptably high with disk testing of piperacillin- tazobactam; the use of enterococcal vancomycin disk breakpoints (zone diameter of > or =17 mm = susceptible) resulted in >20% minor errors but only one very major error. All of the isolates were susceptible to minocycline; over 90% were susceptible to sparfloxacin, levofloxacin, and clinafloxacin; and 88% were susceptible to rifampin. None was susceptible to vancomycin. When Chryseobacterium or Myroides species are isolated from serious infections, susceptibility testing by broth microdilution should be performed and therapy should be guided by those results.

This article has been cited by other articles:

• Ozkalay, N., Anil, M., Agus, N., Helvaci, M., Sirti, S. (2006). Community-Acquired Meningitis and Sepsis Caused by Chryseobacterium meningosepticum in a Patient Diagnosed with Thalassemia Major.. J. Clin. Microbiol. 44: 3037-3039 [Abstract] [Full Text]  
• Lee, C.-C., Chen, P.-L., Wang, L.-R., Lee, H.-C., Chang, C.-M., Lee, N.-Y., Wu, C.-J., Shih, H.-I, Ko, W.-C. (2006). Fatal Case of Community-Acquired Bacteremia and Necrotizing Fasciitis Caused by Chryseobacterium meningosepticum: Case Report and Review of the Literature.. J. Clin. Microbiol. 44: 1181-1183 [Abstract] [Full Text]  
• Christakis, G. B., Perlorentzou, S. P., Chalkiopoulou, I., Athanasiou, A., Legakis, N. J. (2005). Chryseobacterium indologenes Non-Catheter-Related Bacteremia in a Patient with a Solid Tumor. J. Clin. Microbiol. 43: 2021-2023 [Abstract] [Full Text]  
• Kirby, J. T., Sader, H. S., Walsh, T. R., Jones, R. N. (2004). Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J. Clin. Microbiol. 42: 445-448 [Abstract] [Full Text]  
• Garcia-Saez, I., Hopkins, J., Papamicael, C., Franceschini, N., Amicosante, G., Rossolini, G. M., Galleni, M., Frere, J.-M., Dideberg, O. (2003). The 1.5-A Structure of Chryseobacterium meningosepticum Zinc {beta}-Lactamase in Complex with the Inhibitor, D-Captopril. J. Biol. Chem. 278: 23868-23873 [Abstract] [Full Text]  
• Bellais, S., Poirel, L., Leotard, S., Naas, T., Nordmann, P. (2000). Genetic Diversity of Carbapenem-Hydrolyzing Metallo-beta -Lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob. Agents Chemother. 44: 3028-3034 [Abstract] [Full Text]  
• Bellais, S., Aubert, D., Naas, T., Nordmann, P. (2000). Molecular and Biochemical Heterogeneity of Class B Carbapenem-Hydrolyzing beta -Lactamases in Chryseobacterium meningosepticum. Antimicrob. Agents Chemother. 44: 1878-1886 [Abstract] [Full Text]  
• Bellais, S., Poirel, L., Naas, T., Girlich, D., Nordmann, P. (2000). Genetic-Biochemical Analysis and Distribution of the Ambler Class A beta -Lactamase CME-2, Responsible for Extended-Spectrum Cephalosporin Resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob. Agents Chemother. 44: 1-9 [Abstract] [Full Text]